Tags: US | Muscular Dystrophy Drug

FDA Tentatively Approves First Drug for Muscular Dystrophy

FDA Tentatively Approves First Drug for Muscular Dystrophy

(Copyright Fotolia)

Monday, 19 September 2016 11:40 AM

Federal health regulators have granted tentative approval to a highly contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine.

The Food and Drug Administration said it cleared Sarepta Therapeutics' injection for a rare form of Duchenne muscular dystrophy, a deadly inherited disease that affects boys. It's the first FDA approval for the degenerative condition, which causes muscle weakness, loss of movement and eventually death.

Monday's announcement comes nearly five months after the agency and a panel of outside advisers panned the drug at a public meeting, saying there was little evidence of its effectiveness. But regulators faced an immense outcry from patient groups and physicians seeking access to the drug.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Health-News
Federal health regulators have granted tentative approval to a highly contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine.The Food and Drug Administration said it cleared Sarepta Therapeutics'...
US, Muscular Dystrophy Drug
120
2016-40-19
Monday, 19 September 2016 11:40 AM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved